BACKGROUND: @entity299 ( @entity299 ) and left ventricular (LV) alterations are frequent complication in @entity454 ( @entity454 ). We determined the prevalence of @entity299 and @entity4346 ( @entity1184 ) in @entity454 @entity1 before renal replacement therapy and 12 months after @entity298 ( @entity298 ). METHODS: A prospective longitudinal of 50 incident @entity298 @entity1 was studied. Demographic and clinical data were recorded and blood assayed at baseline and after 1-year of follow-up. @entity299 and @entity1184 were evaluated by M-mode two-dimensional echocardiography. RESULTS: @entity299 of the mitral and aortic valves and of both valves were noted in 30, 18 and 10% of @entity1 , respectively. After 12 months of @entity298 regimen, 20% @entity1 had aortic, 24% mitral and 8% had @entity730 of both valves. After one year of @entity298 , @entity1184 was 62 and 36% in @entity1 with and without @entity299 , respectively (p   <   0.05). @entity2232 is an independent predictor of @entity299 at the baseline, while @entity842 is inversely an independent predictor at the end of follow-up. CONCLUSIONS: @entity299 is associated with @entity1184 in @entity298 @entity1 . These findings identified a potential role for monitored markers to be incorporated into therapeutic strategies aimed at detection and treatment of @entity65 and prevention strategies.

Valvular calcification and left ventricular modifying in @entity298 XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity2232 :: ('1906', 'Gene') :: ['Endothelin-1'] @entity1184 :: ('MESH:D006984', 'Disease') :: ['LVH'] @entity730 :: ('MESH:D002114', 'Disease') :: ['calcification'] @entity4346 :: ('MESH:D017379', 'Disease') :: ['LV hypertrophy'] @entity842 :: ('MESH:D009569', 'Chemical') :: ['nitric oxide'] @entity65 :: ('MESH:D002318', 'Disease') :: ['cardiovascular complications'] @entity299 :: ('MESH:D006331', 'Disease') :: ['Cardiac valve calcification', 'CVC'] @entity298 :: ('MESH:D010538', 'Disease') :: ['peritoneal dialysis', 'PD'] @entity454 :: ('MESH:D007676', 'Disease') :: ['end-stage renal disease', 'ESRD']
@entity1 :: (9606,Species) :: ['patients']
